Clin2
NCT07664527Possibly a fitNot yet recruiting

Better way to remove inhaled steroid residue from mouth and nose

Asthma

Treatments studied

Part of Immune system & allergy, Lungs & breathing clinical trials.

This study tests a new method for cleaning the medicine (fluticasone propionate) out of your mouth and nose after you use an inhaled corticosteroid. It is for healthy adults and adults with asthma to see if the method reduces the amount of medicine left behind.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You may be a healthy adult or have asthma.
  • You must be willing to stop using your inhaled corticosteroid for 24 hours (oral) or 12 hours (nasal) before study visits.
  • You must not have used corticosteroid pills, injections, or eye drops in the past 4 weeks.
  • You cannot smoke or vape currently.
  • You cannot be allergic to fluticasone propionate, olives/olive oil, or oxymetazoline.
  • You cannot be pregnant or trying to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07282886Recruiting· Phase 2
Ventilation imaging study for asthma patients

This trial uses special imaging to look at how air moves through your lungs. It may help doctors understand asthma better and could lead to better treatments.

Birmingham, Alabama
NCT06940700Not yet recruiting· Phase 2
New inhaled treatment for adults with asthma

This study tests a new inhaled medication (given through a device you breathe in) for adults with asthma. It is designed to reduce inflammation and improve breathing, and may help people who have not found relief with standard daily inhalers.

Chengdu, Sichuan
NCT06429475Recruiting· Phase 3
Anti-inflammatory reliever for asthma in children and teens

This study tests a new way to treat asthma flares in children and teens (ages 6–18) with mild-to-moderate asthma. It aims to see if a quick-relief anti-inflammatory medicine works better than current treatments to prevent severe attacks.

Mtubatuba, KwaZulu-Natal
NCT03762395Recruiting· Phase 2
Study of anti-inflammatory asthma molecules in adults

This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.

Aurora, Colorado
NCT06970080Recruiting· Phase 4
Testing airway shape in adults with asthma

This trial uses advanced imaging to study the shape of airways in adults with asthma who have active symptoms and inflammation. It aims to find out if certain airway shapes affect how well treatments work, which could lead to more personalized asthma care.

Hamilton, Ontario
NCT06908421Recruiting
Smart device and inhaler for better asthma control

This study tests if using a small smart device with your Trimbow inhaler helps you use it correctly and take it as prescribed. It is for people with asthma who already use Trimbow.

Hvidovre, Capital Region

Hear when a new Asthma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.